AriBio Co., Ltd. Announces the Successful Completion of Their End of Phase 2 Meeting With the USFDA
Today AriBio Co., Ltd. announced the completion of the end of phase 2 meeting (EOP2) with the United States Food and Drug Administration (FDA), Division of Neurology 1. The EOP2 meeting, which occurred